Loading clinical trials...
Loading clinical trials...
Clinical studies have established that implantation of bone marrow mononuclear cells (BM-MNCs) or peripheral blood mononuclear cells (PB-MNCs) into ischaemic limbs increases collateral vessel formatio...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nagoya University
NCT05698979 · Buerger Disease, Raynaud Syndrome
NCT02864654 · Critical Limb Ischemia, Arteriosclerosis Obliterans, and more
NCT00912756 · Arteriosclerosis Obliterans
Department of Cardiology, Nagoya University Graduate School of Medicine
Nagoya
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions